Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

BACTERIAL PHYSIOLOGY

An effector with nuclease activity

Bacteria can interact with eukaryotic cells through contractile injection systems (CISs), which are evolutionarily related to the tails of bacteriophages. One type of CISs, extracellular CISs (eCISs), is released extracellularly, followed by binding to the surface of target cells and delivery of toxic effectors. Rocchi, Ericson, Malter et al. studied the interaction between an eCIS from Pseudoalteromonas luteoviolacea called metamorphosis-associated contractile structures (MACs) and insect and mammalian cells. They identified a new MAC effector, which they termed Pseudoalteromonas nuclease effector, that caused cytotoxicity in both cell types. They went on to show that killing was mediated by the nuclease activity of the bacterial effector protein. In sum, the study identifies the first CIS effector with nuclease activity that targets eukaryotic organisms.

References

Original article

  • Rocchi, I., Ericson, C. F., Malter, K. E. et al. A bacterial phage tail-like structure kills eukaryotic cells by injecting a nuclease effector. Cell Rep. 28, 295–301.e4 (2019)

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Andrea Du Toit.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Du Toit, A. An effector with nuclease activity. Nat Rev Microbiol 17, 529 (2019). https://doi.org/10.1038/s41579-019-0246-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41579-019-0246-x

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing